Wasserman, R. L., Melamed, I. R., Stein, M. R., Jolles, S., Norton, M., & Moy, J. N. (2017). Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex(®) 10% Versus Gammaplex(®) 5% in Subjects with Primary Immunodeficiency. J Clin Immunol.
Chicago-стиль цитированияWasserman, Richard L., Isaac R. Melamed, Mark R. Stein, Stephen Jolles, Miranda Norton, and James N. Moy. "Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex(®) 10% Versus Gammaplex(®) 5% in Subjects With Primary Immunodeficiency." J Clin Immunol 2017.
MLA-цитированиеWasserman, Richard L., et al. "Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex(®) 10% Versus Gammaplex(®) 5% in Subjects With Primary Immunodeficiency." J Clin Immunol 2017.